M Vukovic, M Tanic, A Damjanovic, M Pavlovic… - Translational …, 2023 - Elsevier
Background The use tumor-derived cell-free DNA extracted from body fluids is being evaluated for genetic testing in lung cancer. The aim of this study was to explore the …
S Yang, J Zhu, L Yang, H Fa, Y Wang, D Huo… - ACS …, 2024 - ACS Publications
Timely monitoring of circulating tumor DNA (ctDNA) in serum is meaningful for personalized diagnosis and treatment for lung cancer. Cheap and efficient point-of-care testing (POCT) …
ES Kuligina, GA Yanus, EN Imyanitov - Biochemistry (Moscow), 2024 - Springer
Over the past decade, liquid biopsy (LB) has become a routine diagnostic test essential for the treatment of malignant tumors of various localizations. Its capabilities include early …
SAAM Genet, JRE Wolfs, CBAK Vu, M Wolter… - … of Chromatography B, 2023 - Elsevier
Neuron–specific enolase (NSE) is a promising small–cell lung cancer (SCLC) biomarker composed of αγ and γγ isozyme dimers. As the conventional immunoassays are prone to …
SAH van den Wildenberg, SAAM Genet… - Analytical …, 2025 - ACS Publications
Quantification of intact proteins in serum by liquid chromatography high-resolution mass spectrometry (HRMS) may be a useful alternative to bottom-up LC-MS or conventional …
Circulating tumor DNA (ctDNA) is nowadays considered a robust source to search for druggable tumoral genetic alterations, and in some specific settings liquid biopsy (LB) is …
Z Wu, H Zheng, Y Bian, J Weng, R Zeng, L Sun - Analyst, 2024 - pubs.rsc.org
Circulating tumor DNA (ctDNA) is an auspicious tumor biomarker released into the bloodstream by tumor cells, offering abundant information concerning cancer genes. It plays …
SAAM Genet, E Visser, M Youssef-El Soud… - Lung Cancer, 2024 - Elsevier
Objectives Timely diagnosis of lung cancer (LC) is crucial to achieve optimal patient care and outcome. Moreover, the number of procedures required to obtain a definitive diagnosis …
AF Al Mana, K Culp, A Keeler, O Perrera… - Molecular Diagnosis & …, 2024 - Springer
Background Next-generation sequencing is widely used for comprehensive molecular profiling for many cancers including lung cancer. However, the complex workflows and long …